世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床試験における画像診断の世界市場成長(現状と展望)2024-2030年


Global Imaging In Clinical Trials Market Growth (Status and Outlook) 2024-2030

LPI(LPインフォメーション)の最新調査によると、臨床試験における画像診断の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、臨床試験の画像化市場は、レビュー期間中のCAG... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年6月21日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
108 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

LPI(LPインフォメーション)の最新調査によると、臨床試験における画像診断の世界市場規模は2023年に100万米ドルと評価されました。下流市場での需要の増加に伴い、臨床試験の画像化市場は、レビュー期間中のCAGR %で2030年までに百万米ドルの再調整された規模になると予測されています。
この調査レポートは、世界の臨床試験の画像化市場の成長可能性を明らかにしています。臨床試験の画像化は今後の市場でも安定した成長を示すと予想される。しかし、製品の差別化、コストの削減、サプライチェーンの最適化は、臨床試験の画像化を広く採用する上で引き続き重要です。市場関係者は、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供など、臨床試験画像化市場がもたらす絶大な機会を活用する必要がある。
臨床試験は、新しい検査や治療法を研究し、ヒトの健康状態への影響を評価する研究の一種である。
主な特徴
この調査レポートは、臨床試験におけるイメージング市場を様々な側面から分析し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、臨床試験における画像診断市場の現在の規模と成長の概要を提供します。過去のデータ、タイプ別(サービス、ソフトウェアなど)の市場細分化、地域別内訳などが含まれます。
市場促進要因と課題:政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、臨床試験イメージング市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、臨床試験におけるイメージング市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれます。また、新興企業や市場に影響を与える可能性のある企業にもスポットを当てています。
技術開発:この調査レポートは、臨床試験における画像診断業界の最新の技術開発について掘り下げることができます。これには、臨床試験における画像診断技術の進歩、臨床試験における画像診断の新規参入、臨床試験における画像診断の新規投資、臨床試験における画像診断の将来を形作るその他の技術革新が含まれます。
川下の事業者の好み:本レポートは、画像診断臨床試験市場における顧客の購買行動や採用動向を明らかにします。このレポートには、顧客の購買意思決定に影響を与える要因、臨床試験用画像診断製品の嗜好などが含まれます。
政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブが画像診断臨床試験市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置など、画像診断臨床試験市場の促進を目的とした施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性この調査レポートは、臨床試験における画像診断市場の環境への影響と持続可能性の側面を評価しています。
市場予測と将来展望:当調査レポートでは、実施した分析に基づいて、臨床試験における画像診断産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を掲載しています。市場関係者が新たなトレンドを活用し、課題を克服し、臨床試験におけるイメージング市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
臨床試験の画像化市場はタイプ別と用途別に分類されます。2019-2030年の期間について、セグメント間の成長により、タイプ別、アプリケーション別の消費額の正確な計算と予測を提供します。
タイプ別セグメント
サービス
ソフトウェア
アプリケーション別
バイオテクノロジー企業
製薬会社
医療機器メーカー
政府機関および学術機関
その他
本レポートではまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
バイオクリニカ
パレクセル・インターナショナル・コーポレーション
イントリンシック・イメージング
ワールドケア・クリニカル
ICON plc
キオシス メディカル イメージング
メディアン・テクノロジーズ
ナビタスライフサイエンス(TAKEソリューションズ)
ミント・メディカルGmbH
レイディアント・セージ・ベンチャーズ
レゾナンス・ヘルス


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imaging In Clinical Trials Market Size 2019-2030
2.1.2 Imaging In Clinical Trials Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Imaging In Clinical Trials Segment by Type
2.2.1 Services
2.2.2 Software
2.3 Imaging In Clinical Trials Market Size by Type
2.3.1 Imaging In Clinical Trials Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Imaging In Clinical Trials Market Size Market Share by Type (2019-2024)
2.4 Imaging In Clinical Trials Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Medical Device Manufacturers
2.4.4 Government and Academic Institutions
2.4.5 Others
2.5 Imaging In Clinical Trials Market Size by Application
2.5.1 Imaging In Clinical Trials Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Imaging In Clinical Trials Market Size Market Share by Application (2019-2024)
3 Imaging In Clinical Trials Market Size by Player
3.1 Imaging In Clinical Trials Market Size Market Share by Players
3.1.1 Global Imaging In Clinical Trials Revenue by Players (2019-2024)
3.1.2 Global Imaging In Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Imaging In Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Imaging In Clinical Trials by Regions
4.1 Imaging In Clinical Trials Market Size by Regions (2019-2024)
4.2 Americas Imaging In Clinical Trials Market Size Growth (2019-2024)
4.3 APAC Imaging In Clinical Trials Market Size Growth (2019-2024)
4.4 Europe Imaging In Clinical Trials Market Size Growth (2019-2024)
4.5 Middle East & Africa Imaging In Clinical Trials Market Size Growth (2019-2024)
5 Americas
5.1 Americas Imaging In Clinical Trials Market Size by Country (2019-2024)
5.2 Americas Imaging In Clinical Trials Market Size by Type (2019-2024)
5.3 Americas Imaging In Clinical Trials Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imaging In Clinical Trials Market Size by Region (2019-2024)
6.2 APAC Imaging In Clinical Trials Market Size by Type (2019-2024)
6.3 APAC Imaging In Clinical Trials Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Imaging In Clinical Trials by Country (2019-2024)
7.2 Europe Imaging In Clinical Trials Market Size by Type (2019-2024)
7.3 Europe Imaging In Clinical Trials Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imaging In Clinical Trials by Region (2019-2024)
8.2 Middle East & Africa Imaging In Clinical Trials Market Size by Type (2019-2024)
8.3 Middle East & Africa Imaging In Clinical Trials Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Imaging In Clinical Trials Market Forecast
10.1 Global Imaging In Clinical Trials Forecast by Regions (2025-2030)
10.1.1 Global Imaging In Clinical Trials Forecast by Regions (2025-2030)
10.1.2 Americas Imaging In Clinical Trials Forecast
10.1.3 APAC Imaging In Clinical Trials Forecast
10.1.4 Europe Imaging In Clinical Trials Forecast
10.1.5 Middle East & Africa Imaging In Clinical Trials Forecast
10.2 Americas Imaging In Clinical Trials Forecast by Country (2025-2030)
10.2.1 United States Imaging In Clinical Trials Market Forecast
10.2.2 Canada Imaging In Clinical Trials Market Forecast
10.2.3 Mexico Imaging In Clinical Trials Market Forecast
10.2.4 Brazil Imaging In Clinical Trials Market Forecast
10.3 APAC Imaging In Clinical Trials Forecast by Region (2025-2030)
10.3.1 China Imaging In Clinical Trials Market Forecast
10.3.2 Japan Imaging In Clinical Trials Market Forecast
10.3.3 Korea Imaging In Clinical Trials Market Forecast
10.3.4 Southeast Asia Imaging In Clinical Trials Market Forecast
10.3.5 India Imaging In Clinical Trials Market Forecast
10.3.6 Australia Imaging In Clinical Trials Market Forecast
10.4 Europe Imaging In Clinical Trials Forecast by Country (2025-2030)
10.4.1 Germany Imaging In Clinical Trials Market Forecast
10.4.2 France Imaging In Clinical Trials Market Forecast
10.4.3 UK Imaging In Clinical Trials Market Forecast
10.4.4 Italy Imaging In Clinical Trials Market Forecast
10.4.5 Russia Imaging In Clinical Trials Market Forecast
10.5 Middle East & Africa Imaging In Clinical Trials Forecast by Region (2025-2030)
10.5.1 Egypt Imaging In Clinical Trials Market Forecast
10.5.2 South Africa Imaging In Clinical Trials Market Forecast
10.5.3 Israel Imaging In Clinical Trials Market Forecast
10.5.4 Turkey Imaging In Clinical Trials Market Forecast
10.5.5 GCC Countries Imaging In Clinical Trials Market Forecast
10.6 Global Imaging In Clinical Trials Forecast by Type (2025-2030)
10.7 Global Imaging In Clinical Trials Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Bioclinica
11.1.1 Bioclinica Company Information
11.1.2 Bioclinica Imaging In Clinical Trials Product Offered
11.1.3 Bioclinica Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bioclinica Main Business Overview
11.1.5 Bioclinica Latest Developments
11.2 PAREXEL International Corporation
11.2.1 PAREXEL International Corporation Company Information
11.2.2 PAREXEL International Corporation Imaging In Clinical Trials Product Offered
11.2.3 PAREXEL International Corporation Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PAREXEL International Corporation Main Business Overview
11.2.5 PAREXEL International Corporation Latest Developments
11.3 Intrinsic Imaging
11.3.1 Intrinsic Imaging Company Information
11.3.2 Intrinsic Imaging Imaging In Clinical Trials Product Offered
11.3.3 Intrinsic Imaging Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Intrinsic Imaging Main Business Overview
11.3.5 Intrinsic Imaging Latest Developments
11.4 WorldCare Clinical, LLC
11.4.1 WorldCare Clinical, LLC Company Information
11.4.2 WorldCare Clinical, LLC Imaging In Clinical Trials Product Offered
11.4.3 WorldCare Clinical, LLC Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 WorldCare Clinical, LLC Main Business Overview
11.4.5 WorldCare Clinical, LLC Latest Developments
11.5 ICON plc
11.5.1 ICON plc Company Information
11.5.2 ICON plc Imaging In Clinical Trials Product Offered
11.5.3 ICON plc Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 ICON plc Main Business Overview
11.5.5 ICON plc Latest Developments
11.6 KEOSYS Medical Imaging
11.6.1 KEOSYS Medical Imaging Company Information
11.6.2 KEOSYS Medical Imaging Imaging In Clinical Trials Product Offered
11.6.3 KEOSYS Medical Imaging Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 KEOSYS Medical Imaging Main Business Overview
11.6.5 KEOSYS Medical Imaging Latest Developments
11.7 MEDIAN Technologies
11.7.1 MEDIAN Technologies Company Information
11.7.2 MEDIAN Technologies Imaging In Clinical Trials Product Offered
11.7.3 MEDIAN Technologies Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MEDIAN Technologies Main Business Overview
11.7.5 MEDIAN Technologies Latest Developments
11.8 Navitas Life Sciences(TAKE Solutions)
11.8.1 Navitas Life Sciences(TAKE Solutions) Company Information
11.8.2 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Product Offered
11.8.3 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Navitas Life Sciences(TAKE Solutions) Main Business Overview
11.8.5 Navitas Life Sciences(TAKE Solutions) Latest Developments
11.9 Mint Medical GmbH
11.9.1 Mint Medical GmbH Company Information
11.9.2 Mint Medical GmbH Imaging In Clinical Trials Product Offered
11.9.3 Mint Medical GmbH Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mint Medical GmbH Main Business Overview
11.9.5 Mint Medical GmbH Latest Developments
11.10 Radiant Sage Ventures
11.10.1 Radiant Sage Ventures Company Information
11.10.2 Radiant Sage Ventures Imaging In Clinical Trials Product Offered
11.10.3 Radiant Sage Ventures Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Radiant Sage Ventures Main Business Overview
11.10.5 Radiant Sage Ventures Latest Developments
11.11 Resonance Health
11.11.1 Resonance Health Company Information
11.11.2 Resonance Health Imaging In Clinical Trials Product Offered
11.11.3 Resonance Health Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Resonance Health Main Business Overview
11.11.5 Resonance Health Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our LPI (LP Information) latest study, the global Imaging In Clinical Trials market size was valued at US$ million in 2023. With growing demand in downstream market, the Imaging In Clinical Trials is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Imaging In Clinical Trials market. Imaging In Clinical Trials are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Imaging In Clinical Trials. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Imaging In Clinical Trials market.
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
Key Features:
The report on Imaging In Clinical Trials market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Imaging In Clinical Trials market. It may include historical data, market segmentation by Type (e.g., Services, Software), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Imaging In Clinical Trials market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Imaging In Clinical Trials market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Imaging In Clinical Trials industry. This include advancements in Imaging In Clinical Trials technology, Imaging In Clinical Trials new entrants, Imaging In Clinical Trials new investment, and other innovations that are shaping the future of Imaging In Clinical Trials.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Imaging In Clinical Trials market. It includes factors influencing customer ' purchasing decisions, preferences for Imaging In Clinical Trials product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Imaging In Clinical Trials market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Imaging In Clinical Trials market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Imaging In Clinical Trials market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Imaging In Clinical Trials industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Imaging In Clinical Trials market.
Market Segmentation:
Imaging In Clinical Trials market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Services
Software
Segmentation by application
Biotechnology Companies
Pharmaceutical Companies
Medical Device Manufacturers
Government and Academic Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bioclinica
PAREXEL International Corporation
Intrinsic Imaging
WorldCare Clinical, LLC
ICON plc
KEOSYS Medical Imaging
MEDIAN Technologies
Navitas Life Sciences(TAKE Solutions)
Mint Medical GmbH
Radiant Sage Ventures
Resonance Health



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imaging In Clinical Trials Market Size 2019-2030
2.1.2 Imaging In Clinical Trials Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Imaging In Clinical Trials Segment by Type
2.2.1 Services
2.2.2 Software
2.3 Imaging In Clinical Trials Market Size by Type
2.3.1 Imaging In Clinical Trials Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Imaging In Clinical Trials Market Size Market Share by Type (2019-2024)
2.4 Imaging In Clinical Trials Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Medical Device Manufacturers
2.4.4 Government and Academic Institutions
2.4.5 Others
2.5 Imaging In Clinical Trials Market Size by Application
2.5.1 Imaging In Clinical Trials Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Imaging In Clinical Trials Market Size Market Share by Application (2019-2024)
3 Imaging In Clinical Trials Market Size by Player
3.1 Imaging In Clinical Trials Market Size Market Share by Players
3.1.1 Global Imaging In Clinical Trials Revenue by Players (2019-2024)
3.1.2 Global Imaging In Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global Imaging In Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Imaging In Clinical Trials by Regions
4.1 Imaging In Clinical Trials Market Size by Regions (2019-2024)
4.2 Americas Imaging In Clinical Trials Market Size Growth (2019-2024)
4.3 APAC Imaging In Clinical Trials Market Size Growth (2019-2024)
4.4 Europe Imaging In Clinical Trials Market Size Growth (2019-2024)
4.5 Middle East & Africa Imaging In Clinical Trials Market Size Growth (2019-2024)
5 Americas
5.1 Americas Imaging In Clinical Trials Market Size by Country (2019-2024)
5.2 Americas Imaging In Clinical Trials Market Size by Type (2019-2024)
5.3 Americas Imaging In Clinical Trials Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imaging In Clinical Trials Market Size by Region (2019-2024)
6.2 APAC Imaging In Clinical Trials Market Size by Type (2019-2024)
6.3 APAC Imaging In Clinical Trials Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Imaging In Clinical Trials by Country (2019-2024)
7.2 Europe Imaging In Clinical Trials Market Size by Type (2019-2024)
7.3 Europe Imaging In Clinical Trials Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imaging In Clinical Trials by Region (2019-2024)
8.2 Middle East & Africa Imaging In Clinical Trials Market Size by Type (2019-2024)
8.3 Middle East & Africa Imaging In Clinical Trials Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Imaging In Clinical Trials Market Forecast
10.1 Global Imaging In Clinical Trials Forecast by Regions (2025-2030)
10.1.1 Global Imaging In Clinical Trials Forecast by Regions (2025-2030)
10.1.2 Americas Imaging In Clinical Trials Forecast
10.1.3 APAC Imaging In Clinical Trials Forecast
10.1.4 Europe Imaging In Clinical Trials Forecast
10.1.5 Middle East & Africa Imaging In Clinical Trials Forecast
10.2 Americas Imaging In Clinical Trials Forecast by Country (2025-2030)
10.2.1 United States Imaging In Clinical Trials Market Forecast
10.2.2 Canada Imaging In Clinical Trials Market Forecast
10.2.3 Mexico Imaging In Clinical Trials Market Forecast
10.2.4 Brazil Imaging In Clinical Trials Market Forecast
10.3 APAC Imaging In Clinical Trials Forecast by Region (2025-2030)
10.3.1 China Imaging In Clinical Trials Market Forecast
10.3.2 Japan Imaging In Clinical Trials Market Forecast
10.3.3 Korea Imaging In Clinical Trials Market Forecast
10.3.4 Southeast Asia Imaging In Clinical Trials Market Forecast
10.3.5 India Imaging In Clinical Trials Market Forecast
10.3.6 Australia Imaging In Clinical Trials Market Forecast
10.4 Europe Imaging In Clinical Trials Forecast by Country (2025-2030)
10.4.1 Germany Imaging In Clinical Trials Market Forecast
10.4.2 France Imaging In Clinical Trials Market Forecast
10.4.3 UK Imaging In Clinical Trials Market Forecast
10.4.4 Italy Imaging In Clinical Trials Market Forecast
10.4.5 Russia Imaging In Clinical Trials Market Forecast
10.5 Middle East & Africa Imaging In Clinical Trials Forecast by Region (2025-2030)
10.5.1 Egypt Imaging In Clinical Trials Market Forecast
10.5.2 South Africa Imaging In Clinical Trials Market Forecast
10.5.3 Israel Imaging In Clinical Trials Market Forecast
10.5.4 Turkey Imaging In Clinical Trials Market Forecast
10.5.5 GCC Countries Imaging In Clinical Trials Market Forecast
10.6 Global Imaging In Clinical Trials Forecast by Type (2025-2030)
10.7 Global Imaging In Clinical Trials Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Bioclinica
11.1.1 Bioclinica Company Information
11.1.2 Bioclinica Imaging In Clinical Trials Product Offered
11.1.3 Bioclinica Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bioclinica Main Business Overview
11.1.5 Bioclinica Latest Developments
11.2 PAREXEL International Corporation
11.2.1 PAREXEL International Corporation Company Information
11.2.2 PAREXEL International Corporation Imaging In Clinical Trials Product Offered
11.2.3 PAREXEL International Corporation Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 PAREXEL International Corporation Main Business Overview
11.2.5 PAREXEL International Corporation Latest Developments
11.3 Intrinsic Imaging
11.3.1 Intrinsic Imaging Company Information
11.3.2 Intrinsic Imaging Imaging In Clinical Trials Product Offered
11.3.3 Intrinsic Imaging Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Intrinsic Imaging Main Business Overview
11.3.5 Intrinsic Imaging Latest Developments
11.4 WorldCare Clinical, LLC
11.4.1 WorldCare Clinical, LLC Company Information
11.4.2 WorldCare Clinical, LLC Imaging In Clinical Trials Product Offered
11.4.3 WorldCare Clinical, LLC Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 WorldCare Clinical, LLC Main Business Overview
11.4.5 WorldCare Clinical, LLC Latest Developments
11.5 ICON plc
11.5.1 ICON plc Company Information
11.5.2 ICON plc Imaging In Clinical Trials Product Offered
11.5.3 ICON plc Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 ICON plc Main Business Overview
11.5.5 ICON plc Latest Developments
11.6 KEOSYS Medical Imaging
11.6.1 KEOSYS Medical Imaging Company Information
11.6.2 KEOSYS Medical Imaging Imaging In Clinical Trials Product Offered
11.6.3 KEOSYS Medical Imaging Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 KEOSYS Medical Imaging Main Business Overview
11.6.5 KEOSYS Medical Imaging Latest Developments
11.7 MEDIAN Technologies
11.7.1 MEDIAN Technologies Company Information
11.7.2 MEDIAN Technologies Imaging In Clinical Trials Product Offered
11.7.3 MEDIAN Technologies Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 MEDIAN Technologies Main Business Overview
11.7.5 MEDIAN Technologies Latest Developments
11.8 Navitas Life Sciences(TAKE Solutions)
11.8.1 Navitas Life Sciences(TAKE Solutions) Company Information
11.8.2 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Product Offered
11.8.3 Navitas Life Sciences(TAKE Solutions) Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Navitas Life Sciences(TAKE Solutions) Main Business Overview
11.8.5 Navitas Life Sciences(TAKE Solutions) Latest Developments
11.9 Mint Medical GmbH
11.9.1 Mint Medical GmbH Company Information
11.9.2 Mint Medical GmbH Imaging In Clinical Trials Product Offered
11.9.3 Mint Medical GmbH Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mint Medical GmbH Main Business Overview
11.9.5 Mint Medical GmbH Latest Developments
11.10 Radiant Sage Ventures
11.10.1 Radiant Sage Ventures Company Information
11.10.2 Radiant Sage Ventures Imaging In Clinical Trials Product Offered
11.10.3 Radiant Sage Ventures Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Radiant Sage Ventures Main Business Overview
11.10.5 Radiant Sage Ventures Latest Developments
11.11 Resonance Health
11.11.1 Resonance Health Company Information
11.11.2 Resonance Health Imaging In Clinical Trials Product Offered
11.11.3 Resonance Health Imaging In Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Resonance Health Main Business Overview
11.11.5 Resonance Health Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(clinical trials)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る